tiprankstipranks
Matinas BioPharma (DE:6LJ0)
FRANKFURT:6LJ0
Germany Market

Matinas BioPharma (6LJ0) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

6LJ0 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Matinas
BioPharma
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

6LJ0 Stock 12 Month Forecast

There Are No Analyst Ratings for DE:6LJ0 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

6LJ0 Financial Forecast

6LJ0 Earnings Forecast

The previous quarter’s earnings for 6LJ0 were -€0.89.
The previous quarter’s earnings for 6LJ0 were -€0.89.

6LJ0 Sales Forecast

The previous quarter’s earnings for 6LJ0 were €0.00.
The previous quarter’s earnings for 6LJ0 were €0.00.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - xAI Analyst forecast on DE:6LJ0
TipRanks - xAI
TipRanks - xAI
€0.17
Hold
243.12%
Upside
Reiterated
08/27/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on DE:6LJ0
TipRanks - PerPlexity
TipRanks - PerPlexity
€0.15€0.15
Sell
200.23%
Upside
Downgraded
08/27/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on DE:6LJ0
TipRanks - Google
TipRanks - Google
€0.17
Hold
231.11%
Upside
Upgraded
08/27/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on DE:6LJ0
TipRanks - OpenAI
TipRanks - OpenAI
€0.16€0.16
Hold
224.25%
Upside
Reiterated
08/27/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on DE:6LJ0
TipRanks - Anthropic
TipRanks - Anthropic
€0.16
Sell
217.39%
Upside
Reiterated
08/27/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on DE:6LJ0
TipRanks - DeepSeek
TipRanks - DeepSeek
€0.16€0.16
Hold
222.54%
Upside
Reiterated
08/26/26
AI Generated ArticleAI Generated Article
Analyst Type
Any
Any
AI Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - xAI Analyst forecast on DE:6LJ0
TipRanks - xAI
TipRanks - xAI
€0.17
Hold
243.12%
Upside
Reiterated
08/27/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on DE:6LJ0
TipRanks - PerPlexity
TipRanks - PerPlexity
€0.15€0.15
Sell
200.23%
Upside
Downgraded
08/27/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on DE:6LJ0
TipRanks - Google
TipRanks - Google
€0.17
Hold
231.11%
Upside
Upgraded
08/27/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on DE:6LJ0
TipRanks - OpenAI
TipRanks - OpenAI
€0.16€0.16
Hold
224.25%
Upside
Reiterated
08/27/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on DE:6LJ0
TipRanks - Anthropic
TipRanks - Anthropic
€0.16
Sell
217.39%
Upside
Reiterated
08/27/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on DE:6LJ0
TipRanks - DeepSeek
TipRanks - DeepSeek
€0.16€0.16
Hold
222.54%
Upside
Reiterated
08/26/26
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ODTXOdyssey Therapeutics, Inc.
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
GPCRStructure Therapeutics, Inc. Sponsored ADR
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Matinas BioPharma

3 Months
PerPlexity BiotechnologyTipRanks - PerPlexity
Success Rate
1/2 ratings generated profit
50%
Average Return
+2.40%
Copying PerPlexity Biotechnology's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +2.40% per trade.
1 Year
PerPlexity BiotechnologyTipRanks - PerPlexity
Success Rate
1/2 ratings generated profit
50%
Average Return
+2.40%
Copying PerPlexity Biotechnology's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +2.40% per trade.
2 Years
PerPlexity BiotechnologyTipRanks - PerPlexity
Success Rate
1/2 ratings generated profit
50%
Average Return
+2.40%
Copying PerPlexity Biotechnology's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +2.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

6LJ0 Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, 6LJ0 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 6LJ0 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

6LJ0 Stock Forecast FAQ

What is DE:6LJ0’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:6LJ0’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:6LJ0, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Matinas BioPharma a Buy, Sell or Hold?
      Currently, no data Available
      What is Matinas BioPharma’s share price target?
      Currently, no data Available
      What do analysts say about Matinas BioPharma?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Matinas BioPharma?
      To buy shares of DE:6LJ0, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.